Graduate and career programs, LinkedIn networks and support for patient-centric community trials head the list of the Pharmaceutical Research and Manufacturers of America’s (PhRMA) 2022 efforts to push for greater trial diversity, according to the group’s recent report on equity in healthcare.

PhRMA held its second annual graduate summit and career expo, dubbed Pathways to Success, in 2022, drawing in more than 600 attendees from 224 schools, connecting them with biopharma leaders and giving them views of what it’s like to work in industry from research, tech, marketing, legal and accounting perspectives.

Similarly, the group launched the PhRMA Talent Community on LinkedIn to help overcome job entry barriers, sending more than 1,300 resumes from students and early professionals directly to sponsors that belong to the trade group.

PhRMA also provided a grant to the Yale School of Medicine, Morehouse School of Medicine, and Vanderbilt University Medical Center, to launch Equitable Breakthroughs in Medicine Development (EQBMED), an initiative that is bringing together a diverse group of stakeholders to run community trial sites focusing on the patient voice.

The report also references multiple resources it issued last year, including a report on drug access and adherence inequities, and a series of health equity charts that highlight the patient journey through the healthcare system and the barriers underserved communities may encounter.

Access the full report here: https://onphr.ma/3ZGeR5m.